Oxiquim S.A.

SNSE:OXIQUIM Stock Report

Market Cap: CL$204.1b

Oxiquim Past Earnings Performance

Past criteria checks 5/6

Oxiquim has been growing earnings at an average annual rate of 12.6%, while the Chemicals industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 10.4% per year. Oxiquim's return on equity is 24.3%, and it has net margins of 11.7%.

Key information

12.6%

Earnings growth rate

12.5%

EPS growth rate

Chemicals Industry Growth13.1%
Revenue growth rate10.4%
Return on equity24.3%
Net Margin11.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

May 25
Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

Oxiquim's (SNSE:OXIQUIM) Shareholders May Want To Dig Deeper Than Statutory Profit

Apr 07
Oxiquim's (SNSE:OXIQUIM) Shareholders May Want To Dig Deeper Than Statutory Profit

Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

Jun 10
Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

Are Dividend Investors Making A Mistake With Oxiquim S.A. (SNSE:OXIQUIM)?

Apr 22
Are Dividend Investors Making A Mistake With Oxiquim S.A. (SNSE:OXIQUIM)?

Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

Apr 01
Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

Oxiquim S.A.'s (SNSE:OXIQUIM) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 11
Oxiquim S.A.'s (SNSE:OXIQUIM) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

Feb 18
Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

Did You Participate In Any Of Oxiquim's (SNSE:OXIQUIM) Incredible 355% Return?

Jan 27
Did You Participate In Any Of Oxiquim's (SNSE:OXIQUIM) Incredible 355% Return?

Has Oxiquim (SNSE:OXIQUIM) Got What It Takes To Become A Multi-Bagger?

Dec 28
Has Oxiquim (SNSE:OXIQUIM) Got What It Takes To Become A Multi-Bagger?

Oxiquim S.A. (SNSE:OXIQUIM) On An Uptrend: Could Fundamentals Be Driving The Stock?

Dec 07
Oxiquim S.A. (SNSE:OXIQUIM) On An Uptrend: Could Fundamentals Be Driving The Stock?

Revenue & Expenses Breakdown

How Oxiquim makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SNSE:OXIQUIM Revenue, expenses and earnings (CLP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24228,04026,70043,7450
30 Jun 24219,23225,30243,1210
31 Mar 24216,23223,65542,9930
31 Dec 23214,64923,89641,9210
30 Sep 23221,90424,93042,2040
30 Jun 23243,73327,08843,3570
31 Mar 23258,54727,22043,3860
31 Dec 22264,69529,25242,9020
30 Sep 22262,66328,62441,3670
30 Jun 22238,87425,71038,4700
31 Mar 22213,13424,85035,5580
31 Dec 21191,12820,72733,8700
30 Sep 21170,94718,47141,2330
30 Jun 21161,25218,27637,0190
31 Mar 21155,70816,97234,2510
31 Dec 20158,13517,21931,0360
30 Sep 20158,11316,72017,7620
30 Jun 20155,56915,36817,8890
31 Mar 20155,07515,87416,5920
31 Dec 19152,02115,61816,1990
30 Sep 19154,65514,77017,0530
30 Jun 19157,88116,01817,2940
31 Mar 19158,87015,26317,1530
31 Dec 18156,50214,30217,2190
30 Sep 18151,35113,53416,9530
30 Jun 18146,84712,68516,4810
31 Mar 18145,20818,05517,1310
31 Dec 17144,25318,29417,0780
30 Sep 17141,72221,84216,1110
30 Jun 17138,87721,56215,9730
31 Mar 17135,56616,03315,2710
31 Dec 16134,43816,49214,9980
30 Sep 16136,72913,24214,9870
30 Jun 16140,23813,05415,0050
31 Mar 16142,59112,49315,0020
31 Dec 15144,05912,01314,8910
30 Sep 15144,70810,55414,9400
30 Jun 15142,7509,38614,1990
31 Mar 15140,7349,59813,6630
31 Dec 14140,1198,59213,2450
30 Sep 14128,1748,71510,5060
30 Jun 14129,3777,66711,1220
31 Mar 14134,5706,19511,7000
31 Dec 13133,3145,39211,6000

Quality Earnings: OXIQUIM has high quality earnings.

Growing Profit Margin: OXIQUIM's current net profit margins (11.7%) are higher than last year (11.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: OXIQUIM's earnings have grown by 12.6% per year over the past 5 years.

Accelerating Growth: OXIQUIM's earnings growth over the past year (7.1%) is below its 5-year average (12.6% per year).

Earnings vs Industry: OXIQUIM earnings growth over the past year (7.1%) exceeded the Chemicals industry 2.5%.

Return on Equity

High ROE: OXIQUIM's Return on Equity (24.3%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 06:49
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oxiquim S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution